Zydus Lifesciences to acquire 85.6 % stake in Amplitude Surgical
The closing of the Block Acquisition is now expected to be completed by Q3 2025
The closing of the Block Acquisition is now expected to be completed by Q3 2025
Genomics is transforming the future of modern medicine and treatment modalities across specialties
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
FlexiTubes will showcase range of eco-friendly and innovative tube options
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Subscribe To Our Newsletter & Stay Updated